Position in PYXS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$580,532
-$274,041 QoQ
Shares Held
397,625
-46.5% QoQ
Ownership
0.628%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#12
of 78 holders
Holding Since
Dec 2021
15 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in PYXS Over Time
Shares Held
Position Value (USD)
Derivatives in PYXS
reported options exposure · as of Sep 30, 2024CallValue
$174,692
CallShares
47,600
PutValue
$62,023
PutShares
16,900
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026MILLENNIUM MANAGEMENT LLC holds $4,466,124,984 across 340 Biotechnology names. PYXS ranks #290 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JAZZ |
Jazz Pharmaceuticals plc
|
1,262,511 | $238,677,704 | |
| 2 | INSM |
INSMED Inc
|
1,157,786 | $189,321,166 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
3,010,308 | $170,052,298 | |
| 4 | TERN |
Terns Pharmaceuticals, Inc.
|
3,011,558 | $158,769,337 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
447,887 | $148,192,371 | |
| 6 | FOLD |
AMICUS THERAPEUTICS, INC.
|
7,908,459 | $114,356,317 | |
| 7 | ARDX |
Ardelyx, Inc.
|
17,842,370 | $106,875,796 | |
| 8 | BLTE |
Belite Bio, Inc
|
570,088 | $90,894,830 |
All Filings in PYXS
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $580,532 | 397,625 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $854,573 | 743,107 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,810,034 | 815,331 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $3,893,846 | 3,539,860 | Shares | Sole | 2025-08-14 | |
| 2025-06-27 | $3,896,929 | 3,542,663 | Shares | Sole | 2025-07-01 | |
| 2025-03-31 | $2,435,570 | 2,485,276 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $4,650,213 | 2,980,906 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $6,998,609 | 1,906,978 | Shares | Sole | 2024-11-14 | |
| 2024-09-30 | $62,023 | 16,900 | Put | Sole | 2024-11-14 | |
| 2024-09-30 | $174,692 | 47,600 | Call | Sole | 2024-11-14 | |
| 2024-06-30 | $4,425,165 | 1,336,908 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $180,624 | 42,400 | Call | Sole | 2024-05-15 | |
| 2024-03-31 | $2,483,618 | 583,009 | Shares | Sole | 2024-05-15 | |
| 2024-03-31 | $136,320 | 32,000 | Put | Sole | 2024-05-15 | |
| 2023-12-31 | $23,889 | 13,272 | Shares | Sole | 2024-02-14 | |
| 2023-06-30 | $79,047 | 30,878 | Shares | Sole | 2023-08-14 | |
| 2022-12-31 | $41,987 | 31,334 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $176,980 | 89,838 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $339,899 | 142,815 | Shares | Sole | 2022-08-15 | |
| 2021-12-31 | $112,475 | 10,253 | Shares | Sole | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||